CurrentCardio
Get Weekly

Topic · page 26 of 49

Heart failure & cardiomyopathies

HFrEF, HFmrEF, HFpEF, acute HF, cardiomyopathies (HCM, DCM, amyloidosis), myocarditis and inflammatory cardiomyopathy, devices for HF, HF prognosis

Briefs 1,001–1,040 of 1,928 placed here, newest publication first

Briefs in Heart failure & cardiomyopathies

Newest publication first

  1. Circulation

    Speckle-Tracking Strain Echocardiography for the Assessment of Left Ventricular Structure and Function: A Scientific Statement From the American Heart Association

    Guideline or statement

  2. JACC Heart Fail

    Utility of HFpEF Diagnostic Scores to Stratify Cardiac Reserve Among Patients With Dyspnea

    Cross-sectional study

  3. Eur J Heart Fail

    Atrial Cardiomyopathy: From Healthy Atria to Atrial Failure. A Clinical Consensus Statement of the Heart Failure Association of the ESC

    Guideline or statement

  4. Eur J Prev Cardiol

    Genetically predicted iron status and cardiovascular function and structure: a Mendelian randomization study

    Research article

  5. J Am Coll Cardiol

    Guideline-Directed Medical Therapy and Outcomes Among Patients With Heart Failure With Improved Ejection Fraction

    Cohort study

  6. J Am Coll Cardiol

    Optimizing the Primary Prevention of Sudden Cardiac Death in Patients With Heart Failure

    Research article

  7. J Am Coll Cardiol

    Sodium-Glucose Cotransporter 2 Inhibitor With and Without an Aldosterone Antagonist for Heart Failure With Preserved Ejection Fraction: The SOGALDI-PEF Trial

    Randomised controlled trial

  8. Europace

    Left ventricular septal pacing combined with left ventricular pacing improves acute electric resynchronization, hemodynamic responses and clinical outcomes: results of SPORT study

    Cohort study

  9. JAMA Cardiol

    Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart Failure: Findings From the DAPA-HF Randomized Clinical Trial

    Secondary analysis

  10. JAMA Cardiol

    Finerenone According to Frailty in Heart Failure: A Prespecified Analysis of the FINEARTS-HF Randomized Clinical Trial

    Secondary analysis

  11. Eur J Heart Fail

    Intravenous Ferric Carboxymaltose in Heart Failure with Iron Deficiency (FAIR-HF2 DZHK05 trial): Sex-Specific Outcomes

    Secondary analysis

  12. JACC Cardiovasc Imaging

    Cardiac CT and PET for Surveillance of Heart Transplant Recipients: Systematic Review and Bayesian Meta-Analysis

    Meta-analysis

  13. JACC Cardiovasc Imaging

    Prediction of Left Ventricular Filling Pressures Using Natural Shear Waves: Incremental Value Over Conventional Echocardiography

    Diagnostic or prognostic study

  14. JACC Cardiovasc Imaging

    Comparison of 18F-FAPI-42 PET for Detecting Cardiac Fibroblast Activation in Dilated Cardiomyopathy With Histopathology and CMR

    Diagnostic or prognostic study

  15. Eur Heart J

    Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction

    Meta-analysis

  16. J Am Coll Cardiol

    Impact of Body Mass Index, Central Adiposity, and Weight Loss on the Benefits of Tirzepatide in HFpEF: The SUMMIT Trial

    Secondary analysis

  17. JACC Heart Fail

    Global Burden of Heart Failure in Adults Aged 20-49 Years, 1990-2021

    Cross-sectional study

  18. Eur J Heart Fail

    Improved Risk Assessment in Parvovirus B19-Positive Patients with Heart Failure By Multiparametric Analysis of Endomyocardial Biopsy Using Machine Learning Methods

    Cohort study

  19. Eur J Heart Fail

    Effects of Geranylgeranylacetone on Diastolic and Microvascular Function in Patients with Heart Failure with a Preserved Ejection Fraction: A Phase 2, Randomized, Placebo-Controlled, Crossover Trial

    Randomised controlled trial

  20. JACC Heart Fail

    Expanded Definition of Worsening Heart Failure: Impact on Clinical Outcomes and Quality-of-Life Assessment

    Secondary analysis

  21. JACC Heart Fail

    Pharmacist Management and Quality of Care for Heart Failure With Reduced Left Ventricular Ejection Fraction

    Cohort study

  22. Eur J Heart Fail

    Prognostic Impact of Frailty at Admission and in-Hospital Changes of Frailty Status in Elderly Patients with Acute Heart Failure

    Cohort study

  23. Eur J Heart Fail

    Artificial Intelligence Fully Automated Analysis of Handheld Echocardiography in Real-World Patients with Suspected Heart Failure

    Diagnostic or prognostic study

  24. Eur J Heart Fail

    Prognostic Significance of Somatic Mutations in Myeloid Cells of Men with Chronic Heart Failure – Interaction Between Loss of Y Chromosome and Clonal Haematopoiesis

    Cohort study

  25. Eur J Heart Fail

    Changes in Cardiac Structure and Function are Associated with Health-Related Quality of Life in Heart Failure Patients with Reduced Ejection Fraction: Results from the EVALUATE-HF trial

    Secondary analysis

  26. JACC Heart Fail

    Genetic and Phenotypic Characterization of Nexilin (NEXN)–Related Cardiomyopathy: Results From a Multicentric Study

    Cohort study

  27. Eur Heart J

    Artificial intelligence-enabled electrocardiography and echocardiography to track preclinical progression of transthyretin amyloid cardiomyopathy

    Cohort study

  28. Eur J Heart Fail

    Characteristics and Outcomes of Patients with Heart Failure and History of Malignancy: Data from Swedish Heart Failure Registry and the National Cancer Register

    Cohort study

  29. Eur J Heart Fail

    Computational Modelling of Myocardial Metabolism in Patients with Advanced Heart Failure

    Mechanistic study

  30. Eur J Heart Fail

    Cardio-Microcurrent Device Treatment for Heart Failure with Reduced Ejection Fraction: Results from the C-MIC II Open-Label Randomized Controlled Trial

    Randomised controlled trial

  31. Eur J Prev Cardiol

    Associations of residential green space and natural environment with heart failure: the mediating effect of air pollution and physical activity

    Cohort study

  32. Eur J Heart Fail

    Immune Dysregulation as a Key Driver of Peripartum Cardiomyopathy – an Exploratory Advanced Imaging and Biomarker Study

    Mechanistic study

  33. Eur J Heart Fail

    Coordinated Expression of BMP10/ALK1/endoglin—Proteins that Drive Embryonic Cardiac and Vascular Morphogenesis—in Patients with Heart Failure: The EMPEROR Program

    Secondary analysis

  34. JACC Heart Fail

    Cardiac Magnetic Resonance Imaging vs Coronary Angiography as Primary Strategy in Newly Diagnosed Heart Failure

    Randomised controlled trial

  35. Eur Heart J

    Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonance

    Cohort study

  36. Eur J Prev Cardiol

    The diagnostic yield of an elaborate workup for comorbidities in a real-life heart failure with preserved ejection fraction outpatient population

    Cohort study

  37. Eur J Heart Fail

    Effects of Empagliflozin on Uric Acid Levels During Acute Heart Failure Recompensation: A Sub-Analysis of the EMPAG-HF Trial (Effects of Empagliflozin on Diuresis and Renal Function in Patients with Acute Decompensated Heart Failure)

    Secondary analysis

  38. Eur Heart J

    Cardiac amyloidosis detection from a single echocardiographic video clip: a novel artificial intelligence-based screening tool

    Diagnostic or prognostic study

  39. JACC Cardiovasc Imaging

    Disease Progression in Exercise-Induced Arrhythmogenic Cardiomyopathy Compared With Arrhythmogenic Right Ventricular Cardiomyopathy

    Cohort study

  40. JACC Cardiovasc Imaging

    Uncertain Clinical Relevance of Serial Bone Scintigraphy Findings in Treated Transthyretin Amyloid Cardiomyopathy

    Cohort study

All 1,928 Briefs in ExploreShowing Briefs 1,001–1,040 of 1,928, newest first